Ankylosing spondylitis: Research Studies

1 Related Result(s)

  1. (ASLeap) Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis

    Escalating the dose of Cosentyx is currently one approach for treating certain rheumatologic conditions. The purpose of this study is to discover if it is...